Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-09-23Clinical Trial Update: A First-in-human Trial of GEN3017 in Hodgkin Lymphoma and Non-Hodgkin Lymphoma [Phase 1, Phase 2]
A first-in-human phase 1/2 trial of GEN3017 in classical Hodgkin lymphoma and non-Hodgkin lymphoma was terminated, with results posted.
-
CLINICAL_TRIALS research · 2025-09-23Clinical Trial Update: Evaluate Safety of Axicabtagene Ciloleucel Reinfusion (Axi-Cel-2) in Patients With Relapsed and/or Refractory Second Line High-Risk Non-Hodgkin Lymphoma After Standard of Care Axi-Cel [Phase 1]
Phase 1 clinical trial evaluating the safety of reinfusing axicabtagene ciloleucel (Axi-Cel-2) in patients with relapsed/refractory second-l…
-
CLINICAL_TRIALS research · 2025-09-23Clinical Trial Update: SBU-RESET: RElaxation, Stress Reduction and Epigenetics Trial in Cancer Survivors [NA]
The SBU-RESET trial investigates relaxation, stress reduction, and epigenetic approaches in cancer survivors and is currently recruiting. Th…
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: Study to Evaluate the Role of Siltuximab in Treatment of Cytokine Release Syndrome (CRS) and Immune Effector Cell Associated Neurotoxicity (ICANS) Related to CAR-T Cell Therapy [Phase 2]
A Phase 2 clinical trial update notes evaluation of siltuximab for treating cytokine release syndrome (CRS) and ICANS related to CAR-T cell …
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: Safety Study of CC312 in Adult Patients With Relapsed/Refractory CD19 Positive B-cell Hematologic Malignancies [Phase 1]
This clinical trial update describes a Phase 1 safety study of CC312 in adults with relapsed/refractory CD19-positive B-cell hematologic mal…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: GT719 Injection for the Treatment of Recurrent/Refractory CD19 Positive Adult B-cell Malignancies [Phase 1, Phase 2]
GT719 Injection is being studied in a Phase 1/2 trial for recurrent or refractory CD19-positive adult B-cell malignancies, with recruitment …
-
CLINICAL_TRIALS other · 2025-09-15Clinical Trial Update: Evaluation of the Role of Connected Scales in the Therapeutic Care of Hematology Patients [NA]
This clinical trial update reports that the study sponsored by Assistance Publique - Hôpitaux de Paris is evaluating the use of connected sc…
-
CLINICAL_TRIALS trial_result · 2025-09-12Clinical Trial Update: A Safety, Efficacy and Pharmacokinetic Study of BTCT4465A (Mosunetuzumab) as a Single Agent and Combined With Atezolizumab in Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL) [Phase 1, Phase 2]
This clinical trial update reports on safety, efficacy, and pharmacokinetics of mosunetuzumab as a single agent and with atezolizumab in chr…
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: Obinutuzumab, Venetoclax, and Lenalidomide in Treating Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma [Phase 1]
A Phase 1 clinical trial update evaluating the combination of obinutuzumab, venetoclax, and lenalidomide in patients with relapsed or refrac…
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: An Open-label, Single-arm Clinical Study to Evaluate the Safety and Preliminary Efficacy of OriV508 Injection in Treating Relapsed/Refractory Hematological Malignancies [EARLY_Phase 1]
This open-label, single-arm Phase 1 study is currently recruiting to evaluate the safety and preliminary efficacy of OriV508 injections in a…
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: Homoharringtonine, BCL-2 Inhibitor, Rituximab, and Prednisone in Relapsed/Refractory Diffuse Large B-Cell Lymphoma [Phase 1, Phase 2]
This document outlines a Phase 1/2 clinical trial evaluating a combination of homoharringtonine, a BCL-2 inhibitor, rituximab, and prednison…
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: Cord Blood Transplant in Adults With Blood Cancers [Phase 2]
Phase 2 trial evaluating cord blood transplant in adults with blood cancers is currently recruiting. Conditions include acute myeloid leukem…
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: A Study Investigating the Change in Metabolism Phenotype in Paediatric, Adolescent & Young Adults With Hodgkin or Non-Hodgkin Lymphoma. [Phase 1]
A Phase 1 clinical trial led by Murdoch Children's Research Institute is investigating changes in metabolism phenotype in paediatric, adoles…
-
CLINICAL_TRIALS trial_result · 2025-09-05Clinical Trial Update: TmCD19-IL18 in CD19+ Cancers [Phase 1]
A Phase 1 clinical trial evaluating TmCD19-IL18 for CD19-positive cancers, with Non-Hodgkin lymphoma as the condition, currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-05Clinical Trial Update: A Post-treatment Program to Identify and Manage Complications Related to Oncology or Hematology Treatments in Cancer Survivors. [NA]
This clinical trial update describes a post-treatment program to identify and manage complications related to oncology or hematology treatme…
-
CLINICAL_TRIALS trial_result · 2025-09-05Clinical Trial Update: Notch 1 Mutation in Chronic Lymphocytic Leukemia and Non-Hodgkin's Lymphoma Patient
This ClinicalTrials.gov entry (NCT07157579) from Sohag University notes a study on Notch 1 mutation in chronic lymphocytic leukemia and non-…
-
CLINICAL_TRIALS research · 2025-08-29Clinical Trial Update: Wearable Sensors and Molecular Omics to Detect and Mitigate Cell Therapy Adverse Events
A completed Stanford-led clinical trial evaluating wearable sensors and molecular omics approaches to detect and mitigate adverse events dur…
-
CLINICAL_TRIALS trial_result · 2025-08-28Clinical Trial Update: A Study to Evaluate AB308 in Combination With AB122 in Participants With Advanced Malignancies [Phase 1]
The Phase 1 study evaluating AB308 in combination with AB122 in participants with advanced malignancies has been completed.
-
CLINICAL_TRIALS trial_result · 2025-08-22Clinical Trial Update: Ciprofloxacin vs Ceftazidime for Empirical Treatment of High-Risk Neutropenic Fever in Children With Hematologic Malignancies [Phase 4]
Phase 4 trial comparing ciprofloxacin to ceftazidime as empirical therapy for high-risk febrile neutropenia in children with hematologic can…
-
CLINICAL_TRIALS trial_result · 2025-08-21Clinical Trial Update: A Study of JNJ-64264681 in Participants With Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia [Phase 1]
This update reports the completion of a Phase 1 study evaluating JNJ-64264681 in participants with non-Hodgkin lymphoma and chronic lymphocy…
-
CLINICAL_TRIALS trial_result · 2025-08-21Clinical Trial Update: A Study of JNJ-64264681 and JNJ-67856633 in Participants With Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia [Phase 1]
This is a completed Phase 1 clinical trial update for Janssen investigational agents JNJ-64264681 and JNJ-67856633 in participants with Non-…
-
CLINICAL_TRIALS trial_result · 2025-08-21Clinical Trial Update: A Study of the MALT1 Inhibitor JNJ-67856633 and Ibrutinib in Combination in B-cell NHL and CLL [Phase 1]
A Phase 1 study evaluated the combination of the MALT1 inhibitor JNJ-67856633 with Ibrutinib in patients with chronic lymphocytic leukemia a…
-
CLINICAL_TRIALS trial_result · 2025-08-20Clinical Trial Update: Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma [Phase 1]
Phase 1 trial of MT-601 in relapsed/refractory lymphoma shows safety and preliminary efficacy signals in both non-Hodgkin lymphoma and Hodgk…
-
CLINICAL_TRIALS trial_result · 2025-08-19Clinical Trial Update: Phase 1-2 MAHCT w/ TCell Depleted Graft w/ Simultaneous Infusion Conventional and Regulatory T Cell [Phase 1, Phase 2]
A completed Phase 1/2 study from Stanford evaluated a haploidentical hematopoietic cell transplantation approach using a T-cell depleted gra…
-
CLINICAL_TRIALS research · 2025-08-19Clinical Trial Update: Goal Management Training for Adult Survivors of Childhood Leukemia and Non-Hodgkins Lymphoma With Neurocognitive Sequelae [NA]
Clinical trial update for a study evaluating Goal Management Training for adult survivors of childhood acute lymphoblastic leukemia and chil…